MSJAMA: Industry funding of clinical trials: benefit or bias?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2003-07-02

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1001/JAMA.290.1.113PMID 12837722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct-to-Consumer Promotion of Prescription Drugs

  2012cited by this paper
• Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust.

  2003cited by this paper
• Ethical principles for medical research involving human subjects

  2003cited by this paper
• The price of innovation: new estimates of drug development costs.

  2003cited by this paper
• Stopping medical research to save money: a broken pact with researchers and patients.

  2003cited by this paper
• PhysicianIndustry Relations. Part 1: Individual Physicians

  2002cited by this paper
• Academic freedom in clinical research.

  2002cited by this paper
• Ethics of undisclosed payments to doctors recruiting patients in clinical trials.

  2002cited by this paper
• America's other drug problem: how the drug industry distorts medicine and politics.

  2002cited by this paper
• Medical innovation and institutional interdependence: rethinking university-industry connections.

  2002cited by this paper
• Collaborating with industry--choices for the academic medical center.

  2002cited by this paper
• Sponsorship, authorship, and accountability.

  2001cited by this paper
• Societal responsibilities of clinical trial sponsors

  2001cited by this paper
• Sponsorship, authorship, and accountability.

  2001cited by this paper
• Commentary: Early discontinuation violates Helsinki principles.

  2001cited by this paper
• Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility.

  2001cited by this paper
• Industry-sponsored clinical research: a double-edged sword.

  2001cited by this paper
• Societal responsibilities of clinical trial sponsors. Lack of commercial pay off is not a legitimate reason for stopping a trial.

  2001cited by this paper
• Company, academics argue over data

  2000cited by this paper
• The uncertainty principle and industry-sponsored research.

  2000cited by this paper
• Assessing faculty financial relationships with industry: A case study.

  2000cited by this paper
• Uneasy alliance--clinical investigators and the pharmaceutical industry.

  2000cited by this paper
• Evaluation of conflict of interest in economic analyses of new drugs used in oncology.

  1999cited by this paper
• The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus.

  1998cited by this paper
• Publishing sensitive data: who calls the shots? Long-suppressed study finally sees light of day.

  1997cited by this paper
• Long-Suppressed Study Finally Sees Light of Day

  1997cited by this paper
• Publishing sensitive data: who calls the shots? Secretiveness found widespread in life sciences.

  1997cited by this paper
• Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.

  1997cited by this paper
• Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

  1996cited by this paper
• Influences on the Quality of Published Drug Studies

  1996cited by this paper
• The Quality of Drug Studies Published in Symposium Proceedings

  1996cited by this paper
• A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.

  1994cited by this paper
• Underreporting research is scientific misconduct.

  1990cited by this paper
• Source of funding and outcome of clinical trials

  1986cited by this paper

• Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment

  2025cites this paper
• Six Decades of Scientific Output: A Bibliometric Analysis of Research Contributions from the National Institute of Neurology and Neurosurgery "Manuel Velasco Suárez".

  2025cites this paper
• Immunotherapy or Targeted Therapy Versus Best Supportive Care for Advanced Gastric Cancer: A Systematic Review and Meta-analysis of Randomized Trials

  2025cites this paper
• Recruitment and retention strategies for improving representation in clinical research: A meta-synthesis

  2025cites this paper
• Clinical trials in small-cell lung cancer treatment: a cross-sectional analysis of trial discontinuation and non-publication

  2025cites this paper
• Corporate ‘Capture Strategies’ Impacting Human and Ecosystem Health

  2025cites this paper
• Coevolutionary Analysis of Evidence and Recommendations in STEMI Clinical Practice Guidelines: A 33-Year Meta-Research Study of ACC, AHA, and ESC.

  2025cites this paper
• Investigator Meditation Practice Predicts Efficacy of Child/Adolescent Mindfulness-Based Interventions: A Meta-Analysis.

  2025cites this paper
• Funding, Publication Rate and Characteristics of Paediatric Sleep Apnea Clinical Trials: A Cross‐Sectional Analysis

  2025cites this paper
• Press releases of industry-sponsored clinical trials in oncology: characteristics, timing and financial impact.

  2025cites this paper
• Academic Clinical Trials Submitted to an Institutional Ethics Committee at a Tertiary Care Center: A Retrospective Analysis

  2024cites this paper
• Comparing the Clinical Trial Characteristics of Industry-Funded Trials and Non Industry-Funded Trials

  2024cites this paper
• Evaluation of Control Arm Quality in Recent Radiation Oncology Randomized Clinical Trials

  2024cites this paper
• Methodological quality of systematic reviews on treatments for Parkinson's disease: A cross-sectional study.

  2024cites this paper
• Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial

  2024cites this paper
• Racial and Ethnic Representation in Peripheral Artery Disease Randomized Clinical Trials.

  2024cites this paper
• Why are clinical trials of deep brain stimulation terminated? An analysis of clinicaltrials.gov

  2024cites this paper
• The animal agriculture industry, US universities, and the obstruction of climate understanding and policy

  2024cites this paper
• The Quality in Acute Stroke Care (QASC) global scale-up using a cascading facilitation framework: a qualitative process evaluation

  2024cites this paper
• Characteristics of global radiotherapy trials between 2017 and 2022: A cross-sectional study.

  2023cites this paper
• Comparing the clinical trial characteristics of industry-funded trials and non- industry-funded trials

  2023cites this paper
• Characteristics of endodontic clinical trials registered in clinicalTrials.gov between 2000 and 2022

  2023cites this paper
• Nothing short of a revolution: Novel extended half-life factor VIII replacement products and non-replacement agents reshape the treatment landscape in hemophilia A.

  2023cites this paper
• Discontinuation and nonpublication of nasopharyngeal carcinoma clinical trials.

  2023cites this paper
• Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews.

  2023cites this paper
• Industry’s role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials

  2023cites this paper
• Carbon footprint of industry-sponsored late-stage clinical trials

  2023cites this paper
• Clinical Trials on Colorectal Cancer in South Africa

  2023cites this paper
• Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research

  2023cites this paper
• Stop the Presses (and the Data Collection)! Aggressive Fluids Harm Patients With Acute Pancreatitis: May 2023 Annals of Emergency Medicine Journal Club.

  2023cites this paper
• The Effect of Plant-Based and Mycoprotein-Based Meat Substitute Consumption on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis of Controlled Intervention Trials

  2023cites this paper
• The Invisible Hand of Industry.

  2022cites this paper
• Topical dapsone in the treatment of acne: a systematic review

  2022cites this paper
• Assessing the Robustness of Negative Vascular Surgery Randomized Controlled Trials Using their Reverse Fragility Index.

  2022cites this paper
• FDA Should Re-evaluate All mRNA Vaccines and Revoke Their Use Authorizations (The Short Version).

  2022cites this paper
• Are We Scared of Clinical Trials if Not Sufficiently Informed and Educated?

  2022cites this paper
• Factors associated with reporting of the Prevention of Falls Network Europe (ProFaNE) core outcome set domains in randomized trials on falls in older people: a citation analysis and correlational study

  2022cites this paper
• Systematic reviews: Not always a pain

  2022cites this paper
• Network meta-analysis: What is its purpose in Orthopaedic literature?

  2022cites this paper
• Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients

  2022cites this paper
• Early Discontinuation, Results Reporting, and Publication of Pediatric Clinical Trials.

  2022cites this paper
• Impact of COVID-19 Pandemic Declaration on New Oncology Trial Commencements: An Interrupted Time Series with Segmented Regression Analysis

  2022cites this paper
• Women in cardiology: Between the "glass ceiling" and the "sticky floor".

  2021cites this paper
• A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!

  2021cites this paper
• Anthocyanins, Anthocyanin-Rich Berries, and Cardiovascular Risks: Systematic Review and Meta-Analysis of 44 Randomized Controlled Trials and 15 Prospective Cohort Studies

  2021cites this paper
• Global Representation of Heart Failure Clinical Trial Leaders and Collaborators: A Systematic Bibliometric Review 2000-2020

  2021cites this paper
• Global Representation of Heart Failure Clinical Trial Leaders, Collaborators, and Enrolled Participants: A Bibliometric Review 2000-2020.

  2021cites this paper
• Patch augmentation surgery for rotator cuff repair: the PARCS mixed-methods feasibility study.

  2021cites this paper
• The frequency of medical reversals in a cross-sectional analysis of high-impact oncology journals, 2009–2018

  2021cites this paper
• The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19

  2021cites this paper
• Women in cardiology: Between the "glass ceiling" and the "sticky floor".

  2021cites this paper
• Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week.

  2021cites this paper
• Continuity and change in the drug supply chain: actors, actions, and aversions

  2021cites this paper
• When birds of a feather don't flock together: Diversity and innovation outcomes in international R&D collaborations

  2020cites this paper
• Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review

  2020cites this paper
• The Association Between Sugar-Sweetened Beverages and Child Obesity: Implications for US Policy

  2020cites this paper
• Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders

  2020cites this paper
• Fraudulent Misrepresentation and Fraudulent Concealment in Products Liability in Tort Law in Canada: The Special Relationship Between Drug Companies and Consumers in the Context of the Fraudulent Misrepresentation and Fraudulent Concealment of Data

  2020cites this paper
• Meta-analysis of Usefulness of Phrenic Nerve Stimulation in Central Sleep Apnea.

  2020cites this paper
• Sponsorship of oncology clinical trials in the United States according to age of eligibility

  2020cites this paper
• Methodological Quality of Systematic Reviews and Meta-analysis on Asthma Treatments: A Cross-sectional Study.

  2020cites this paper
• Institutional Corruption of Medical Knowledge Production

  2020cites this paper
• Undue Pharmaceutical Industry Influence in Medical Profession

  2020cites this paper
• At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products

  2020cites this paper
• Out of the Darkness, Into Light: The Scientific Rigor of Lung Cancer Clinical Trials in the Age of Enlightenment.

  2020cites this paper
• Language Bias in Health Research: External Factors That Influence Latent Language Patterns

  2020cites this paper
• Association of Industry Sponsorship With Cancer Clinical Trial Accrual.

  2020cites this paper
• Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli

  2020cites this paper
• GRADEing quality of evidence and its importance in evidence-based practice

  2020cites this paper
• Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.

  2020cites this paper
• A Defence of Industry Funding: Why Banning Private Sponsorship of Scientific Research Is a Bad Idea

  2020cites this paper
• Effect of Commercially Available Synthetic Insulin on the Biofilm Formation in S. aureus and E. coli Bacterial Strains

  2019cites this paper
• Changing Trends in Industry Funding for Surgical Oncologists

  2019cites this paper
• Clinical trials of neurointervention : 2007–2018

  2019cites this paper
• Drug cost avoidance in clinical trials of breast cancer

  2019cites this paper
• Rates of Discontinuation and Nonpublication of Head and Neck Cancer Randomized Clinical Trials.

  2019cites this paper
• Bibliography

  2019cites this paper
• Pharmaconutrition administration on outcomes of elective oncological surgery for gastrointestinal malignancies: is timing everything?-a review of published meta-analyses until the end of 2016.

  2018cites this paper
• Transparency in clinical trial reporting

  2018cites this paper
• The Impact of Source of Funding on the Outcome of Clinical Trials in India

  2018cites this paper
• Benefits and Harms in Pivotal Trials of Oral Centrally Acting Antiobesity Medicines: A Systematic Review and Meta‐Analysis

  2018cites this paper
• Workplace lighting for improving alertness and mood in daytime workers.

  2018cites this paper
• Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation Therapy.

  2018cites this paper
• The downsides of industry-funded development of new therapeutics

  2018cites this paper
• Making medicines

  2018cites this paper
• Model to study the flow and use of knowledge in outsourced knowledge intensive projects: a multi-case study of three vaccine clinical trials in Latin America (countries researched: Colombia, Brazil and Mexico)

  2018cites this paper
• Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review.

  2017cites this paper
• Funding and Bias

  2017cites this paper
• Are we Scared of Clinical Trials if not Sufficiently Informed and Educated?

  2016cites this paper
• Determinants of Citation Impact in Large Clinical Trials in Critical Care: The Role of Investigator-Led Clinical Trials Groups*

  2015cites this paper
• A Comparison of Incremental Costs of Breast Cancer Clinical Trials to Standard of Care

  2015cites this paper
• DETECTION OF ANXIETY DISORDERS IN PRIMARY CARE: A META‐ANALYSIS OF ASSISTED AND UNASSISTED DIAGNOSES

  2015cites this paper
• Industry-funded clinical trials: Beneficial or harmful?

  2015cites this paper
• Effect of timing of pharmaconutrition (immunonutrition) administration on outcomes of elective surgery for gastrointestinal malignancies: a systematic review and meta-analysis.

  2014cites this paper
• Design and execution of clinical trials in orthopaedic surgery

  2014cites this paper
• Incremental costs of prostate cancer trials: Are clinical trials really a burden on a public payer system?

  2013cites this paper
• Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies

  2013cites this paper
• The Invention of an Investment Incentive for Pharmaceutical Innovation

  2012cites this paper
• Protecting Scientific Integrity: The Commercial Speech Doctrine Applied to Industry Publications

  2011cites this paper
• The adequacy of the ethics review process in Malaysia : protection of the interests of mentally incapacitated adults who enrol in clinical trials

  2011cites this paper